Valuation: Yuhan Corporation

Market Cap 5,916B 4.34B 3.76B 3.56B 3.22B 6.04B 416B 6.09B 42.45B 16.33B 211B 16.3B 15.94B 675B P/E 2026 *
38.9x
P/E 2027 * 29.2x
Enterprise Value 5.83B 4.28M 3.71M 3.5M 3.18M 5.95M 410M 6M 41.81M 16.08M 208M 16.05M 15.7M 665M EV / Sales 2026 *
2.49x
EV / Sales 2027 * 2.27x
Free-Float
61.43%
Yield 2026 *
0.72%
Yield 2027 * 0.73%
1 day+0.25%
1 week-1.73%
Current month-5.26%
1 month-5.26%
3 months+2.72%
6 months-20.14%
Current year-29.45%
1 week 77,700
Extreme 77700
81,500
1 month 77,500
Extreme 77500
87,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 19/03/2021
Director of Finance/CFO 58 -
President 67 15/03/2024
Director TitleAgeSince
Chairman 74 19/03/2021
Director/Board Member 71 20/03/2015
Director/Board Member 62 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/06/25 Buy

Chairperson

200 0.0002%
25/06/25 Buy

Chief Executive Officer

720 0.0009%
24/06/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%-1.73%-33.75%+9.70% 4.38B
-0.15%-4.35%+73.64%+32.84% 357B
+0.27%-3.11%+22.62%-20.57% 65.51B
-1.57%-3.58%+38.17%+162.22% 12.25B
+0.70%-6.23%-8.49%-16.91% 7.54B
-1.26%-8.12%-29.64%-16.02% 4.6B
-1.13%-4.33%-34.67%-10.64% 2.93B
-0.51%-5.17%-9.19%+40.98% 2.41B
-0.28%-3.22%-27.62%-29.52% 1.93B
-0.84%-2.60%-25.88%-17.09% 1.66B
Average -0.45%-3.52%-3.48%+13.50% 46.06B
Weighted average by Cap. -0.13%-3.61%+60.14%+26.49%

Financials

2026 *2027 *
Net sales 2,342B 1.72B 1.49B 1.41B 1.28B 2.39B 165B 2.41B 16.81B 6.46B 83.55B 6.45B 6.31B 267B 2,547B 1.87B 1.62B 1.53B 1.39B 2.6B 179B 2.62B 18.28B 7.03B 90.88B 7.02B 6.86B 291B
Net income 156B 114M 99.14M 93.69M 84.96M 159M 10.96B 160M 1.12B 430M 5.56B 429M 420M 17.78B 200B 147M 127M 120M 109M 204M 14.07B 206M 1.44B 552M 7.14B 551M 539M 22.83B
Net Debt -89.35B -65.59M -56.83M -53.7M -48.7M -91.23M -6.28B -91.94M -641M -247M -3.19B -246M -241M -10.19B -133B -97.5M -84.48M -79.83M -72.39M -136M -9.34B -137M -953M -367M -4.74B -366M -358M -15.15B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,082
Date Price Change Volume
15/09/26 ₩79,300.00 +0.25% 217,062
14/09/26 ₩79,100.00 -0.38% 145,503
11/09/26 ₩79,400.00 +0.63% 137,725
10/09/26 ₩78,900.00 -1.38% 409,069
09/09/26 ₩80,000.00 +1.14% 141,783
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
79,300.00KRW
Average target price
114,500.00KRW
Spread / Average Target
+44.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!